Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
J Diabetes Metab Disord
.
2019 Sep 13;18(2):583.
doi: 10.1007/s40200-019-00440-z.
eCollection 2019 Dec.
Authors
Khojasteh Joharchi
1
,
Moosareza Memari
1
,
Eznollah Azargashb
2
,
Navid Saadat
3
Affiliations
1
1Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences (SBUMS), Tehran, Iran.
2
2Department of Social Medicine, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3
3Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
PMID:
31891365
PMCID:
PMC6915167
DOI:
10.1007/s40200-019-00440-z
Abstract
[This corrects the article DOI: 10.1007/s40200-019-00427-w.].
© The Author(s) 2019.
Publication types
Published Erratum